Pharma industry headwinds in remission: ICRA
Revenues of ICRA’s sample set to grow by 7-9 per cent in FY2024; OPM to stabilise at 20.5-21.5 per cent in FY2024
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.